AzTrials
AzTrials

SleepMIDESOMNCT04317677

Effects of Bladder Voiding on Sleep Architecture in Infants

A study testing Study of the effect of bladder voiding on sleep fragmentation during day and night sleep in people with Sleep, run by Hospices Civils de Lyon at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Sleep changes rapidly during the first year of life. Brain maturation is accompanied by sleep consolidation in several episode during day and night (daytime naps and night sleep) and progressive organization during the 24h period (more wake during day et more sleep during night). Read more about this study

Who is it for?
Ages 1 month to 12 months
Conditions the study is for
Sleep
What is being tested?
Study of the effect of bladder voiding on sleep fragmentation during day and night sleep
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
9 Dec 2020to 9 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants of both sex
  • Age ≥1 month and ≤ 12 months
  • Referred to the sleep unit for sleep trouble screening following ALTE (Apparent Life Threatening Event).
  • Patients should benefit from appropriate insurance system
  • Parents who have expressed a willingness to participate in the study, who have signed and dated the informed consent.

Who cannot join

  • Neurological, endocrinal or syndromic diseases :
  • Head and neck congenital malformations
  • Pierre Robin Syndrome
  • Trisomy
  • Achondroplasia
  • Prader Willy syndrome
Show all 10Show fewer
  • Ondine syndrome
  • Cardiac diseases and malformations
  • Weight <2.5 kg
  • Preterm babies (under 37 weeks of gestational age)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Service épilepsie, sommeil et explorations neuropédiatriques, Hôpital Femme mère enfant - Groupement hospitalier Est - HCL

    Bron, 69500

    Patricia FRANCO, MD, PhD, 04.27.85.60.52 ext. +33, patricia.franco@chu-lyon.fr

    Patricia FRANCO, MD, PhD

    Recruiting

Other trials in France

About this study

Sleep changes rapidly during the first year of life. Brain maturation is accompanied by sleep consolidation in several episode during day and night (daytime naps and night sleep) and progressive organization during the 24h period (more wake during day et more sleep during night). In the first months of life, sleep episodes are frequently interrupted by wake, possibly induced by multiple external and internal stimuli. One of this stimulus could be bladder voiding that is particularly frequent in babies. Only one team worked on the link between sleep and bladder voiding and reported that bladder voiding was associated with cortical arousal during a daytime nap in a little group of babies.

In this study, investigators propose to study the relationship between sleep and bladder voiding in a bigger group of infant and during daytime but also nighttime sleep.

Conditions
Sleep
Being tested
Study of the effect of bladder voiding on sleep fragmentation during day and night sleep

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Study of the effect of bladder voiding on sleep fragmentation during day and night sleepOther

    Vigilance state of babies will be continuously recorded during the first 24 hours of hospitalization by polysomnography and actigraphy. In parallel, bladder voiding episodes will be detected with an innovative device placed on babies diapers.

Study groups in NCT04317677
Study groupRoleWhat they receive
Babies hospitalized in the pediatric sleep unitOtherNot described
Receives: Other: Study of the effect of bladder voiding on sleep fragmentation during day and night sleep

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurrence of arousals / awakenings in a timely relation with bladder voiding.

    The occurrence of arousals and awakenings will be determined form polysomnography signals including electroencephalogram (EEG), electrooculogram (EOG) and a electromyogram (EMG). Arousals and awakenings will be scored as defined by the international rules for visual scoring of EEG (AASM manual 2007). Investigators will calculate the percentage of bladder voiding episode leading to arousal / awakening events

    Measured: 24 hours

Secondary outcomes (4)
  1. Sleep stage following bladder voiding events

    Sleep stages will be scored as defined by the international rules (AASM 2007). Investigators will determine the proportion of bladder voiding events leading to a change of sleep stage.

    Measured: 24 hours

  2. EEG frequencies following bladder voiding episodes

    EEG will be quantitatively analyzed and the power spectrum in each frequency band will be determined. Investigators will determine the proportion of bladder voiding events followed by a significant change of EEG frequencies.

    Measured: 24 hours

  3. Heart rate following bladder voiding episode

    EKG will be obtained during the entire record. Investigators will determine the proportion of bladder voiding followed by a significant change of heart rate

    Measured: 24 hours

  4. Activity record with actigraphy in babies

    Coherence analysis between actigraphy and polysomnography records

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2020
  2. Study start9 Dec 2020
  3. Primary completion9 Dec 2025 (estimated)
  4. Study completion9 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04317677
Sponsor's protocol ID
69HCL18_0223
Acronym
MIDESOM
Status last verified
Jan 2025
First submitted
19 Mar 2020
Last updated
30 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Study of the effect of bladder voiding on sleep fragmentation during day and night sleep in people with Sleep, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Patricia FRANCO, Pr (04.27.85.60.52 ext. +33, patricia.franco@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurrence of arousals / awakenings in a timely relation with bladder voiding. (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in